Successful treatment of epidermal growth factor receptor inhibitor-induced periungual inflammation with adapalene

Junichi Hachisuka, Kazuko Doi, Yoichi Moroi, Masutaka Furue

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Epidermal growth factor receptor (EGFR) inhibitors are increasingly used for cancer treatment, but commonly carry dermatologic side effects. Periungual inflammation is a particularly painful condition that additionally worsens quality of life. In this paper, we report 3 cases of successful treatment of periungual inflammation induced by 3 different EGFR inhibitors (gefitinib, erlotinib, and cetuximab) with topically applied adapalene.

Original languageEnglish
Pages (from-to)130-136
Number of pages7
JournalCase Reports in Dermatology
Volume3
Issue number2
DOIs
Publication statusPublished - May 1 2011

All Science Journal Classification (ASJC) codes

  • Dermatology

Fingerprint Dive into the research topics of 'Successful treatment of epidermal growth factor receptor inhibitor-induced periungual inflammation with adapalene'. Together they form a unique fingerprint.

  • Cite this